However, this discovery requires further in vitro and in vivo experimental exploration to elucidate the specific mechanisms by which ELFN1 functions during tumor progression and immunotherapy, which is crucial for advancing immune-based therapeutic strategies for tumors. The gene discussed is ELFN1; the disease is neoplasm.